Drug Info Lab

Edit Answers
1234567891011121314151617181920
Across
  1. 2. Oral agent for relapsed refractory FLT-3 AML
  2. 4. Prevents hemorrhagic cystitis for ifosfamide
  3. 6. Available as implantable wafers
  4. 7. Indication for sipuleucel-T
  5. 9. Anti-CD38 for multiple myeloma
  6. 10. Should never be administered intrathecally
  7. 11. Treats breast cancer; increases risk of endometrial cancer
  8. 12. PARP inhibitor with the most indications
  9. 13. Treatment for ALL that engages T-cells
  10. 16. Used in treatment of testicular cancer; can cause pulmonary toxicity
  11. 17. Virus attenuated in talimogene laherparepvec
  12. 19. Oral version of dacarbazine
  13. 20. Oral agent for advanced/metastatic breast cancer that requires monitoring of CBC for first two months
Down
  1. 1. Used to treat acute phase of irinotecan-induced diarrhea
  2. 3. ALK inhibitor that can treat the mutation T315I
  3. 5. Monoclonal antibody conjugate used for core binding factor AML
  4. 8. Side effect of cetuximab that can indicate therapy is benefitting
  5. 14. MEK inhibitor that is combined with dabrafenib
  6. 15. Highly emetogenic; can cause tinnitus
  7. 18. Treatment for CLL, requires monitoring for tumor lysis syndrome